HOME >> MEDICINE >> NEWS
Stopping medication too soon after receiving a drug-eluting stent raises risk of death

e risk of stent thrombosis lasts for a longer period of time and patients with DES require prolonged thienopyridine therapy (typically for several months).

In a 19-center study of 500 heart attack patients (average age 61 years and 68 percent male) who received a DES and were discharged with prescriptions for thienopyridines, 68 patients (13.6 percent) stopped their medication within 30 days. Those who stopped were:

  • older;
  • less likely to have completed high school;
  • less likely to be married;
  • more likely to avoid health care due to cost;
  • more likely to have pre-existing cardiovascular disease or anemia when they arrived at the hospital; and
  • less likely to have received discharge instructions about their medications or be referred for cardiac rehabilitation.

After one year, 7.5 percent of patients who stopped their medication within the first 30 days had died compared to 0.7 percent of the compliant patients. In addition, 23 percent of those who stopped their medication early were readmitted to the hospital, compared to 14 percent of those who continued their medication, he said.

"The rate of death was significantly higher and the frequency of cardiac hospitalizations was almost twice as great over the next 11 months among those who stopped their thienopyridines as compared to those who continued them," Spertus said.

Researchers said previous studies under controlled conditions found that the combination of DES plus three to six months of antiplatelet medication effectively prevented restenosis for patients with atherosclerosis.

Yet, clinical trials differ from real-world practice where patients may have less intense follow-up or limited access to the medications they need. That's why it was important to see how patients would fare under real-world conditions, including those getting stents on a more emergency basis, such as for treatment of hear
'"/>

Contact: Bridgette McNeill
bridgette.mcneill@heart.org
214-706-1396
American Heart Association
12-Jun-2006


Page: 1 2 3

Related medicine news :

1. Stopping inhaled corticosteroid use causes no problems in cystic fibrosis patient users
2. Stopping antidepressants during pregnancy may lead to symptom recurrence
3. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
4. Heart failure medication does not improve survival, compared to more widely used medication
5. Commonly used pain medications do not prevent Alzheimers disease
6. Standard long-acting insulin as good as newer medications
7. MS patients not receiving medications to slow disease progression, research shows
8. Study sheds light on medication treatment options for bipolar disorder
9. Landmark schizophrenia treatment study reveals that medication alone is not always effective
10. Cost control measures limit patient and physician choice in psychotropic medications
11. Residents in disaster areas face medication adherence dilemmas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... The Aresty Institute of ... finance programs to address the increasingly complex educational needs of today's global executives. ... of sophisticated corporate finance and will increase their ability to confidently take action ...
(Date:3/30/2017)... PA (PRWEB) , ... March 30, 2017 , ... An inventor and manicurist from Greet, ... in my profession I try to help customers maintain clean and healthy feet, so I ... take care of their feet at home, I designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN ...
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... ... 2017 , ... During the last week of March, Chad Kawa, MD of ... in the local community. , Colon cancer is the second leading cause of ... while it is small, confined and easier to treat. If you are 50 or ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to ... develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain ... on finding more effective treatment options, the San Diego Gamma Knife Center ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... , March 30, 2017 Stock-Callers.com navigates ... the research, development, and production of non-electronic medical, surgical, dental, ... Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: BDX), ... (NYSE: BCR ). Download the free research reports ... ...
(Date:3/30/2017)... -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... dose-ranging study of AKCEA-APO(a)-L Rx in patients with ... study is to determine the dose level and frequency ... Phase 3 cardiovascular outcome study. AKCEA-APO(a)-L ... Novartis to develop and commercialize drugs to treat patients ...
(Date:3/29/2017)... CITY , March 29, 2017  Bodycad ... and Drug Administration (FDA) 510(k) clearance for its ... of this truly personalized orthopaedic restoration. Bodycad is ... for a joint reconstruction implant system. ... to optimize personalized restoration of the patient,s unique ...
Breaking Medicine Technology:
Cached News: